Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft

J Clin Oncol. 2012 Feb 1;30(4):e45-8. doi: 10.1200/JCO.2011.36.9678. Epub 2011 Dec 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / secondary
  • Carcinoma, Adenoid Cystic / drug therapy*
  • Carcinoma, Adenoid Cystic / pathology*
  • Clinical Trials, Phase I as Topic / methods*
  • Female
  • Humans
  • Immunoglobulins, Intravenous
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Precision Medicine / methods*
  • Quinazolinones / administration & dosage
  • Treatment Outcome
  • Xenograft Model Antitumor Assays / methods

Substances

  • Antibodies, Monoclonal
  • Immunoglobulins, Intravenous
  • Quinazolinones
  • dacomitinib
  • figitumumab